Evidence brief · Supplement

Astragalus for General immunity

Evidence grade C — Weak

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • General immunityEvidence grade C

    Weak

    Smalllow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: General immunity (grade C).

The evidence in words

The verdict

For general immunity, Astragalus earns evidence grade C (small effect, low consistency) — the evidence is limited or mixed. Weak

How it might work

Polysaccharides and saponins with immune-modulating and antioxidant activity.

How to use it

Standardized extract per product; oncology use under care.

Safety & cautions

Generally safe; immune-stimulating, so caution with immunosuppressants/autoimmunity.

Bottom line

A tonic with genuine adjunctive signals in cancer and kidney contexts; unremarkable as a daily immune booster.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
Standardized extract; oncology use under care.

Goes with

  • AstragalusRead the full Astragalus monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.